Last mentioned: Mar 24, 2026
Two significant initial public offerings, Powerica and Sai Parenterals, opened for subscription today, aiming to raise a combined ₹1,509 crore. Powerica leads the charge with a ₹1,100-crore issue focused on its wind power portfolio, while Sai Parenterals seeks ₹409 crore to bolster its pharmaceutical operations.
Sai Parenterals has officially opened its ₹409-crore initial public offering with a price band of ₹372–392 per share. The launch coincides with a broader surge in Indian capital markets, highlighting investor interest in specialized pharmaceutical manufacturing and sterile injectables.
Sai Parenterals has launched its ₹409-crore initial public offering with a price band of ₹372–392 per share. The offering marks a significant expansion phase for the specialized pharmaceutical manufacturer as it targets the high-growth sterile injectables market.